Table 3:

Post-transplant complications in patients with a functioning graft.

Post-transplant complications	N=39 (%)
Total number of the recipient with pancreas biopsy	4 (10.3%)
Total number of the recipient with pancreas rejection	3 (7.7%)
Total number of recipients with malignancy	26 (66.7%)
Skin	15 (57.7%)
PTLD	4 (15.4%)
Other (leukemia, breast, cervical, renal cell, penile, bladder)	7 (26.9%)
Amputation of lower extremity:	6 (17.9%)
Below knee amputation	2 (33.3%)
Transmetatarsal amputation	2 (33.3%)
Toe amputation	2 (33.3%)
Mean time to amputation (years)	21.3 ± 10.8
Enteric conversion from the bladder-drained pancreas	27 (67.5%)
Mean interval to enteric conversion (years)	4.7 ± 5.2
Reason for enteric conversion
Bladder leak	8 (29.6%)
Hematuria, bleeding	11 (40.7%)
Recurrent UTIs, urethritis	6 (22.2%)
Other	2 (7.4%)
Kidney graft failure	11 (28.2%)
Kidney re-transplant	10 (90.9%)
Average time to failure (years)	19.0 ± 10.8
Reason for kidney graft failure
Chronic rejection	11 (100.0%)
Infectious complications	36 (92.3%)
UTI	27 (75.0%)
CMV, HSV	2 (5.6%)
Cellulitis	3 (8.3%)
Osteomyelitis	2 (5.6%)
Pneumonia	2 (5.6%)
Development of autoimmune disease post-transplant	3 (7.7%)
Rheumatoid arthritis	3 (100%)

Abbreviations: PTLD, post-traumatic lymphoproliferative disorder; UTI, urinary tract infection; CMV, cytomegalovirus; HSV, herpes simplex virus